Human evidence for vasoactive intestinal peptide spans respiratory failure trials, Persistent lung disease experiments, CIRS cohorts, and observational biomarker knowledge — a broader medical evidence foundation than most peptides in recent analysis.Intranasal shipping and delivery strategy